Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 31, 2021
Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registryFlorence A Aeschlimann, Nilanjana Misra, Tarique Hussein, et al.
Cardiology in the Young|February 27, 2025
Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committeePaul Esteso, Scott R Auerbach, Neha Bansal, et al.
Pediatric Cardiology|June 20, 2025
Cardiac Medication Use in ACTION for Duchenne Muscular Dystrophy CardiomyopathyCarol A Wittlieb-Weber, Brian F Birnbaum, Chesney D Castleberry, et al.
Circulation. Heart Failure|August 1, 2024
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH TrialCatherine G Ireland, Danielle S Burstein, Sharlene M Day, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 15, 2020
Pediatric Heart Network Echocardiographic Z Scores: Comparison with Other Published ModelsLeo Lopez, Peter C Frommelt, Steven D Colan, et al.
Circulation. Heart Failure|May 9, 2025
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical TrialConstantin-Cristian Topriceanu, Christoffer Rasmus Vissing, Anna Axelsson Raja, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 25, 2024
Design and implementation of multicenter pediatric and congenital studies with cardiovascular magnetic resonance: Big data in smaller bodiesMichael P DiLorenzo, Simon Lee, Rahul H Rathod, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Pageof 11